Skip to main content
. 2023 Oct 9;80(11):1145–1154. doi: 10.1001/jamaneurol.2023.3542

Figure 2. Dose-Dependent Efficacy of XEN1101.

Figure 2.

All doses were administered with food. For B, responder rate indicates greater than or equal to 50% reduction in FOS frequency from baseline. For C, responder rate indicates less than 50%, greater than or equal to 50%, greater than or equal to 75%. and 100% thresholds. DBP indicates double-blind phase; FOS, focal-onset seizure; NA, not applicable.

aP = .04.

bP < .001.